Drug repurposing for cancer therapy, easier said than done
Author:
Publisher
Elsevier BV
Subject
Cancer Research
Reference98 articles.
1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Bray;CA Cancer J. Clin.,2018
2. Global cancer incidence and mortality rates and trends—an update;Torre;Cancer Epidemiol. Biomarkers Prev.,2016
3. Back to the future: in the era of cost-effectiveness analysis, affordability is a limiting factor for patients’ access to innovative cancer treatments;Aguiar;Value Health Reg. Issues,2019
4. A history of cancer chemotherapy;DeVita;Cancer Res.,2008
5. Barriers for pharmaceutical innovation with focus in cancer drugs, the case of Mexico;Duenas-Gonzalez;Ther. Innov. Regul. Sci.,2019
Cited by 31 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. In Silico Screening of Multi-Domain Targeted Inhibitors for PTK6: A Strategy Integrating Drug Repurposing and Consensus Docking;Pharmaceuticals;2023-12-29
2. Drug repositioning in thyroid cancer treatment: the intriguing case of anti-diabetic drugs;Frontiers in Pharmacology;2023-12-11
3. Traditional Chinese Medicine Formulae QY305 Reducing Cutaneous Adverse Reaction and Diarrhea by its Nanostructure;Advanced Science;2023-12-03
4. ANALYTICAL UV SPECTROSCOPY METHOD DEVELOPMENT AND VALIDATION STUDIES FOR SIMULTANEOUS ESTIMATION OF METFORMIN HCL AND QUERCETIN;INDIAN DRUGS;2023-11-28
5. ChaC1-based drug screenings identify a synergistic lethal effect of auranofin and proteasome inhibitors in hepatocellular carcinoma cells.;2023-08-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3